New chemo combo tested to shrink breast tumors before surgery
NCT ID NCT00295893
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study tested two different chemotherapy regimens, given before surgery, to see which works better for stage II-III breast cancer. Some participants also received trastuzumab, a targeted therapy. The main goal was to see if the tumor disappeared completely by the time of surgery. About 121 people took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010-3000, United States
Conditions
Explore the condition pages connected to this study.